GlassScriptPhysician profile
Roohbakhsh Maher
NPI 1275581357
$2,063.14
in general payments reported to CMS, 2019-2025
22 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $155 · 2021: $30.73 · 2022: $247 · 2024: $125 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $667.74 | 2019 | |
| Novo Nordisk INC | $375.03 | 2024-2025 | Wegovy, Ozempic |
| In2bones USA, LLC | $145.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $125.77 | 2019 | |
| Paragon 28, INC. | $101.09 | 2019 | |
| Integra Lifesciences Corporation | $74.41 | 2019-2021 | |
| Sandoz INC. | $64.03 | 2019 | |
| Amniox Medical, INC. | $60.21 | 2020 | |
| Stryker Corporation | $48.05 | 2022 | |
| Depuy Synthes Sales INC. | $43.39 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.99 | 2020 | |
| Dynavax Technologies Corporation | $39.23 | 2019-2022 | |
| Melinta Therapeutics, LLC | $34.96 | 2019 | |
| Djo, LLC | $34.17 | 2020 | |
| Horizon Therapeutics Plc | $31.74 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $31.25 | 2025 | Apretude |
| Smith+Nephew, INC. | $29.12 | 2022 | |
| Bioventus LLC | $28.51 | 2019 | |
| Glaxosmithkline, LLC. | $25.69 | 2025 | Shingrix, Bexsero |
| Sanofi Pasteur INC. | $21.42 | 2025 | |
| Lilly USA, LLC | $20.89 | 2025 | Mounjaro |
| Convatec INC. | $17.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roohbakhsh Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.